LCLianghua Chen

Lianghua Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lianghua Chen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Haide Li

    Department of Cardiology, Linyi Central Hospital, Linyi, Shandong, China

    1 shared publication
  • Hongbo Tian

    Department of Cardiology Shandong Provincial Hospital Affiliated to Shandong University Ji'nan Shandong China

    1 shared publication
  • Ke Zhang

    Department of Diagnostic and Interventional Radiology Heidelberg University Hospital Heidelberg Germany

    1 shared publication
  • Min Li

    Department of Cardiology Shandong Provincial Hospital Affiliated to Shandong University Jinan China

    1 shared publication
  • Ningling Sun

    Department of Hypertension, People’s Hospital, Peking University, Beijing, China

    1 shared publication
  • Shiliang Jiang

    Department of Cardiology Shandong Provincial Hospital Affiliated to Shandong University Ji'nan Shandong China

    1 shared publication

Latest Publications

  • MicroRNA‐140 attenuates myocardial ischemia‐reperfusion injury through suppressing mitochondria‐mediated apoptosis by targeting YES1

    by Shuguo Yang, Haide Li, Lianghua Chen

    Myocardial ischemia‐reperfusion (I/R) injury is thought to have its detrimental role in coronary heart disease (CHD), which is considered as the foremost cause of death all over the world. However, molecular mechanism in the progression of myocardial I/R injury is still unclear. The goal of this study was to investigate the expression and function of microRNA‐140 (miR‐140) in the process of myocardial I/R injury. The miR‐140 expression level was analyzed in the myocardium with I/R injury and control myocardium using quantitative real‐time polymerase chain reaction. Then the relation between the level of miR‐140 and YES proto‐oncogene 1 (YES1) was also investigated via luciferase reporter assay. Assessment of myocardial infarct size measurement of serum myocardial enzymes and electron microscopy analysis were used for analyzing the effect of miR‐140 on myocardial I/R injury. We also used Western blot analysis to examine the expression levels of the mitochondrial fission–related proteins, Drp1 and Fis1. miR‐140 is downregulated, and YES1 is upregulated after myocardial I/R injury. Overexpression of miR‐140 could reduce the increase related to myocardial I/R injury in infarct size and myocardial enzymes, and it also could inhibit the expression of proteins related to mitochondrial morphology and myocardial I/R‐induced mitochondrial apoptosis by targeting YES1. Taken together, these findings may provide a novel insight into the molecular mechanism of miR‐140 and YES1 in the progression of myocardial I/R injury. MiR‐140 might become a promising therapeutic target for treating myocardial I/R injury.


  • Open Access

    Relationship of renin‐angiotensin system polymorphisms with ambulatory and central blood pressure in patients with hypertension

    by Weizhong Han, Ningling Sun, Lianghua Chen, Shiliang Jiang, Yunchao Chen, Min Li, Hongbo Tian, Ke Zhang, Xiao Han

    This study was conducted to explore whether the renin C‐5312T, angiotensin II type 1 receptor A1166C, and angiotensin‐converting enzyme I/D polymorphisms were associated with ambulatory blood pressure (BP) and central hemodynamics in an untreated hypertensive population. A total of 471 participants with no previous treatment for raised BP were eligible for the study. Ambulatory and central BP were measured. DD carriers had the highest daytime systolic/diastolic BP, nighttime systolic BP, 24‐hour systolic BP, and 24‐hour diastolic BP values, whereas carriers of DD had higher central systolic BP and augmentation index compared with those with the II genotype. Multivariate regression analysis demonstrated that DD genotype was independently associated with 24‐hour systolic BP, 24‐hour diastolic BP, central systolic BP, and central augmentation index. There was an independent association of the angiotensin‐converting enzyme polymorphism with central and ambulatory BP in Chinese patients with hypertension.